BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Shi BM, Lu W, Ji K, Wang YF, Xiao S, Wang XY. Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma. World J Gastroenterol 2017; 23(20): 3713-3720 [PMID: 28611524 DOI: 10.3748/wjg.v23.i20.3713]
URL: https://www.wjgnet.com/1948-5182/full/v23/i20/3713.htm
Number Citing Articles
1
José Debes, Pablo Romagnoli, Jhon Prieto, Marco Arrese, Angelo Mattos, André Boonstra. Serum Biomarkers for the Prediction of Hepatocellular CarcinomaCancers 2021; 13(7): 1681 doi: 10.3390/cancers13071681
2
Hamdy E.A. Ali, Ahmed A. Emam, Ahmed A. Zeeneldin, Reham Srour, Reda Tabashy, Eman D. El-Desouky, Zakaria Y. Abd Elmageed, Abdel-Hady A. Abdel-Wahab. Circulating miR-26a, miR-106b, miR-107 and miR-133b stratify hepatocellular carcinoma patients according to their response to transarterial chemoembolizationClinical Biochemistry 2019; 65: 45 doi: 10.1016/j.clinbiochem.2019.01.002
3
Farzaneh Moshiri, Alessandro Salvi, Laura Gramantieri, Angelo Sangiovanni, Paola Guerriero, Giuseppina De Petro, Cristian Bassi, Laura Lupini, Arash Sattari, Douglas Cheung, Dario Veneziano, Giovanni Nigita, Ram C. Shankaraiah, Nazario Portolani, Paolo Carcoforo, Francesca Fornari, Luigi Bolondi, Antonio Frassoldati, Silvia Sabbioni, Massimo Colombo, Carlo M. Croce, Massimo Negrini. Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinomaOncotarget 2018; 9(20): 15350 doi: 10.18632/oncotarget.24601
4
Lavinia Alice Balaceanu. Biomarkers <i>vs</i> imaging in the early detection of hepatocellular carcinoma and prognosisWorld Journal of Clinical Cases 2019; 7(12): 1367-1382 doi: 10.12998/wjcc.v7.i12.1367
5
Xiao-Na Liu, Dan-Ni Cui, Yu-Fang Li, Yun-He Liu, Gang Liu, Lei Liu. Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosisWorld Journal of Gastroenterology 2019; 25(29): 4199 doi: 10.3748/wjg.v25.i29.4199
Abstract() |  Core Tip() |  Full Article(HTML)() | Times Cited  (0) | Total Visits (0) | Open
6
Long Chen, Yu Chen, Yuan-Ling Feng, Yan Zhu, Li-Quan Wang, Shen Hu, Pu Cheng. Tumor circulome in the liquid biopsies for digestive tract cancer diagnosis and prognosisWorld Journal of Clinical Cases 2020; 8(11): 2066-2080 doi: 10.12998/wjcc.v8.i11.2066
7
Fen Hu, Yonglian Wang, Xueqing Wu, Shan Liu, Haiying Ren, Wenhui Zhou. Overexpressed miR-106b-5p promotes epithelial-mesenchymal transition in endometriosis by targeting PTENReproductive Toxicology 2022;  doi: 10.1016/j.reprotox.2022.07.007
8
Surendra Kumar Sagar. miR-106b as an emerging therapeutic target in cancerGenes & Diseases 2022; 9(4): 889 doi: 10.1016/j.gendis.2021.02.002
9
Xiao-Na Liu, Dan-Ni Cui, Yu-Fang Li, Yun-He Liu, Gang Liu, Lei Liu. Multiple “Omics” data-based biomarker screening for hepatocellular carcinoma diagnosisWorld Journal of Gastroenterology 2019; 25(30): 4199-4212 doi: 10.3748/wjg.v25.i30.4199
10
Tudor Mocan, André L. Simão, Rui E. Castro, Cecília M. P. Rodrigues, Artur Słomka, Bingduo Wang, Christian Strassburg, Aliona Wöhler, Arnulf G. Willms, Miroslaw Kornek. Liquid Biopsies in Hepatocellular Carcinoma: Are We Winning?Journal of Clinical Medicine 2020; 9(5): 1541 doi: 10.3390/jcm9051541
11
Li Zhao, Qian Yang, Jianbo Liu. Clinical Value Evaluation of microRNA-324-3p and Other Available Biomarkers in Patients With HBV Infection–Related Hepatocellular CarcinomaOpen Forum Infectious Diseases 2021; 8(6) doi: 10.1093/ofid/ofab108
12
Xiaojing Li, Xianpeng Zeng. Shikonin suppresses progression and epithelial–mesenchymal transition in hepatocellular carcinoma (HCC) cells by modulating miR‐106b/SMAD7/TGF‐β signaling pathwayCell Biology International 2020; 44(2): 467 doi: 10.1002/cbin.11247